StockData
Penumbra Inc logo

Penumbra Inc (PEN) stock

PENNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3074% above fair value
$320.62−0.29 (-0.09%)

Close on Nov 16, 2026Market cap $12.64BP/E 80.8Yield –

Penumbra r&d expenses

Research and development expenses are spending on new products and technology.

Penumbra's R&D Expenses for the twelve months ending Sep 30, 2026 was $94.93M, up 7.9% year over year. For fiscal 2025 it was $89.77M, down 5.3% from the year before. Over ten years it grew 17.4% a year on average. The highest annual figure on record is $104.55M in fiscal 2021.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$89.77M-5.3%
FY2024Dec 31, 2024$94.78M+12.3%
FY2023Dec 31, 2023$84.42M+6.3%
FY2022Dec 31, 2022$79.41M-24.1%
FY2021Dec 31, 2021$104.55M+16.1%
FY2020Dec 31, 2020$90.05M+74.1%
FY2019Dec 31, 2019$51.72M+43.0%
FY2018Dec 31, 2018$36.17M+14.2%
FY2017Dec 31, 2017$31.66M+32.6%
FY2016Dec 31, 2016$23.88M+32.4%
FY2015Dec 31, 2015$18.03M+15.7%
FY2014Dec 31, 2014$15.58M+10.6%
FY2013Dec 31, 2013$14.08M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$25.36M+11.8%
Q2 FY2026Jun 30, 2026$25.40M+9.4%
Q1 FY2026Mar 31, 2026$22.38M+1.4%
Q4 FY2025Dec 31, 2025$21.79M+8.9%
Q3 FY2025Sep 30, 2025$22.68M-10.0%
Q2 FY2025Jun 30, 2025$23.22M-6.9%
Q1 FY2025Mar 31, 2025$22.08M-10.4%
Q4 FY2024Dec 31, 2024$20.01M-8.8%
Q3 FY2024Sep 30, 2024$25.21M+20.3%
Q2 FY2024Jun 30, 2024$24.94M+15.8%
Q1 FY2024Mar 31, 2024$24.63M+23.2%
Q4 FY2023Dec 31, 2023$21.94M+22.1%
Q3 FY2023Sep 30, 2023$20.96M-1.7%
Q2 FY2023Jun 30, 2023$21.54M+10.1%
Q1 FY2023Mar 31, 2023$19.99M-2.8%
Q4 FY2022Dec 31, 2022$17.96M-65.5%
Q3 FY2022Sep 30, 2022$21.32M+27.4%
Q2 FY2022Jun 30, 2022$19.56M+10.3%
Q1 FY2022Mar 31, 2022$20.56M+13.8%
Q4 FY2021Dec 31, 2021$52.00M+167.3%
Q3 FY2021Sep 30, 2021$16.73M-52.1%
Q2 FY2021Jun 30, 2021$17.74M-21.9%
Q1 FY2021Mar 31, 2021$18.08M+39.6%
Q4 FY2020Dec 31, 2020$19.46M+51.3%
Q3 FY2020Sep 30, 2020$34.92M+154.3%
Q2 FY2020Jun 30, 2020$22.73M+68.8%
Q1 FY2020Mar 31, 2020$12.95M+11.0%
Q4 FY2019Dec 31, 2019$12.86M+18.3%
Q3 FY2019Sep 30, 2019$13.73M+51.0%
Q2 FY2019Jun 30, 2019$13.46M+64.3%
Q1 FY2019Mar 31, 2019$11.67M+45.6%
Q4 FY2018Dec 31, 2018$10.87M+29.4%
Q3 FY2018Sep 30, 2018$9.09M+11.8%
Q2 FY2018Jun 30, 2018$8.19M+1.2%
Q1 FY2018Mar 31, 2018$8.01M+13.9%
Q4 FY2017Dec 31, 2017$8.40M+37.4%
Q3 FY2017Sep 30, 2017$8.13M–
Q2 FY2017Jun 30, 2017$8.09M–
Q1 FY2017Mar 31, 2017$7.03M–
Q4 FY2016Dec 31, 2016$6.11M–

More Penumbra figures

See a number that looks wrong?